Trials / Completed
CompletedNCT03478306
Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Glostrup University Hospital, Copenhagen · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effect of melatonin 4 mg on circadian rhythm and visual function of patients with diabetes mellitus. Half of the patients will receive melatonin (arm-1) and the other half will receive placebo (arm-2), both groups in 3 weeks. After a week of washout, the patients will cross over to the other treatment arm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Melatonin 4 mg Tablet | Participants are randomized into arm 1 or arm2, recieving melatonin or placebo, respectively, for 21 days, followed by 1 week of washout, and then swichting to the contralateral treatment arm. |
Timeline
- Start date
- 2018-03-27
- Primary completion
- 2021-06-12
- Completion
- 2021-06-12
- First posted
- 2018-03-27
- Last updated
- 2021-08-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03478306. Inclusion in this directory is not an endorsement.